Cerus PE Ratio 2006-2019 | CERS

Current and historical p/e ratio for Cerus (CERS) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Cerus PE ratio as of December 09, 2019 is 0.00.
Cerus PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-12-09 3.87 0.00
2019-09-30 5.16 $-0.52 0.00
2019-06-30 5.62 $-0.50 0.00
2019-03-31 6.23 $-0.47 0.00
2018-12-31 5.07 $-0.44 0.00
2018-09-30 7.21 $-0.42 0.00
2018-06-30 6.67 $-0.43 0.00
2018-03-31 5.48 $-0.49 0.00
2017-12-31 3.38 $-0.56 0.00
2017-09-30 2.73 $-0.59 0.00
2017-06-30 2.51 $-0.61 0.00
2017-03-31 4.45 $-0.63 0.00
2016-12-31 4.35 $-0.62 0.00
2016-09-30 6.21 $-0.64 0.00
2016-06-30 6.24 $-0.67 0.00
2016-03-31 5.93 $-0.66 0.00
2015-12-31 6.32 $-0.66 0.00
2015-09-30 4.54 $-0.76 0.00
2015-06-30 5.19 $-0.74 0.00
2015-03-31 4.17 $-0.73 0.00
2014-12-31 6.24 $-0.68 0.00
2014-09-30 4.01 $-0.53 0.00
2014-06-30 4.15 $-0.67 0.00
2014-03-31 4.80 $-0.60 0.00
2013-12-31 6.45 $-0.65 0.00
2013-09-30 6.72 $-0.62 0.00
2013-06-30 4.42 $-0.41 0.00
2013-03-31 4.42 $-0.42 0.00
2012-12-31 3.16 $-0.42 0.00
2012-09-30 3.40 $-0.51 0.00
2012-06-30 3.32 $-0.38 0.00
2012-03-31 4.02 $-0.41 0.00
2011-12-31 2.80 $-0.35 0.00
2011-09-30 2.12 $-0.25 0.00
2011-06-30 3.00 $-0.40 0.00
2011-03-31 2.91 $-0.41 0.00
2010-12-31 2.46 $-0.43 0.00
2010-09-30 3.84 $-0.50 0.00
2010-06-30 3.16 $-0.56 0.00
2010-03-31 2.79 $-0.61 0.00
2009-12-31 1.99 $-0.71 0.00
2009-09-30 2.19 $-0.78 0.00
2009-06-30 1.03 $-0.89 0.00
2009-03-31 0.68 $-0.98 0.00
2008-12-31 0.70 $-0.91 0.00
2008-09-30 4.13 $-1.07 0.00
2008-06-30 4.09 $-1.09 0.00
2008-03-31 5.77 $-1.37 0.00
2007-12-31 6.51 $-1.42 0.00
2007-09-30 8.73 $-0.96 0.00
2007-06-30 6.76 $-0.73 0.00
2007-03-31 6.75 $-0.35 0.00
2006-12-31 5.86 $-0.18 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.574B $0.061B
Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $151.583B 20.94
Abbott Laboratories (ABT) United States $151.168B 27.57
Stryker (SYK) United States $76.313B 25.66
Boston Scientific (BSX) United States $61.440B 29.00
Baxter (BAX) United States $42.463B 25.75
Essilor Luxottica (ESLOY) France $33.468B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.550B 19.17
Terumo (TRUMY) Japan $27.062B 0.00
Lonza Group Ag (LZAGY) Switzerland $25.531B 0.00
Coloplast (CLPBY) Denmark $25.294B 39.03
ResMed (RMD) United States $21.653B 39.94
Smith & Nephew SNATS (SNN) United Kingdom $19.279B 0.00
Sunny Optical Technology (SNPTF) China $19.151B 0.00
Insulet (PODD) United States $11.373B 541.06
Bio-Rad Laboratories (BIO) United States $11.201B 53.76
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
William Demant Holdings (WILYY) Denmark $7.531B 0.00
Hill-Rom Holdings (HRC) United States $7.203B 21.24
Perrigo (PRGO) Ireland $7.117B 13.27
Canopy Growth (CGC) Canada $6.501B 0.00
Haemonetics (HAE) United States $6.146B 41.53
Shandong Weigao Medical Polymer (SHWGF) China $5.743B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 0.00
NuVasive (NUVA) United States $3.890B 30.64
ICU Medical (ICUI) United States $3.830B 24.97
Neogen (NEOG) United States $3.545B 59.33
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.165B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.121B 0.00
Quidel (QDEL) United States $2.954B 28.04
Aurora Cannabis (ACB) Canada $2.648B 0.00
National Vision Holdings (EYE) United States $2.432B 54.89
Agios Pharmaceuticals (AGIO) United States $2.411B 0.00
Cardiovascular Systems (CSII) United States $1.577B 0.00
InMode (INMD) Israel $1.516B 0.00
AtriCure (ATRC) United States $1.226B 0.00
Aphria (APHA) $1.187B 0.00
VAREX IMAGING (VREX) United States $1.162B 23.28
Phibro Animal Health (PAHC) United States $0.994B 18.61
NanoString Technologies (NSTG) United States $0.944B 0.00
Lantheus Holdings (LNTH) United States $0.802B 20.04
Eagle Pharmaceuticals (EGRX) United States $0.771B 29.55
TG Therapeutics (TGTX) United States $0.709B 0.00
Quanterix (QTRX) United States $0.705B 0.00
LeMaitre Vascular (LMAT) United States $0.698B 39.25
PetIQ (PETQ) United States $0.675B 16.46
Omeros (OMER) United States $0.655B 0.00
Surmodics (SRDX) United States $0.570B 59.24
HEXO (HEXO) $0.537B 0.00
OraSure Technologies (OSUR) United States $0.492B 29.52
Owens & Minor (OMI) United States $0.474B 17.53
MacroGenics (MGNX) United States $0.474B 0.00
Organigram Holdings (OGI) Canada $0.405B 0.00
Utah Medical Products (UTMD) United States $0.396B 28.71
Meridian Bioscience (VIVO) United States $0.396B 13.62
BioLife Solutions (BLFS) United States $0.331B 134.92
Zynex (ZYXI) United States $0.329B 37.22
Bovie Medical (APYX) United States $0.275B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.269B 0.00
United Health Products (UEEC) United States $0.249B 0.00
Viemed Healthcare (VMD) United States $0.242B 25.52
Vapotherm (VAPO) United States $0.227B 0.00
Repro-Med Systems (KRMD) United States $0.195B 0.00
Liberty Health Sciences (LHSIF) Canada $0.192B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.164B 0.00
Chimerix (CMRX) United States $0.151B 0.00
Female Health (VERU) United States $0.148B 0.00
Rockwell Medical (RMTI) United States $0.141B 0.00
Cytosorbents (CTSO) United States $0.128B 0.00
Fonar (FONR) United States $0.128B 9.03
MTech Acquisition (KERN) United States $0.114B 0.00
United-Guardian (UG) United States $0.091B 23.15
Oramed Pharmaceuticals (ORMP) United States $0.080B 0.00
Chembio Diagnostics (CEMI) United States $0.069B 0.00
Nephros (NEPH) United States $0.064B 0.00
Surface Oncology (SURF) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.017B 0.00
GUARDION HEALTH (GHSI) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00